Cargando…

Correction to: Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma

Detalles Bibliográficos
Autores principales: Zhang, Ao, Zhong, Guanqing, Wang, Luocan, Cai, Rongzeng, Han, Runkun, Xu, Caixia, Chen, Shulin, Sun, Peng, Chen, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641160/
https://www.ncbi.nlm.nih.gov/pubmed/34856989
http://dx.doi.org/10.1186/s12935-021-02369-x
_version_ 1784609452076302336
author Zhang, Ao
Zhong, Guanqing
Wang, Luocan
Cai, Rongzeng
Han, Runkun
Xu, Caixia
Chen, Shulin
Sun, Peng
Chen, Hao
author_facet Zhang, Ao
Zhong, Guanqing
Wang, Luocan
Cai, Rongzeng
Han, Runkun
Xu, Caixia
Chen, Shulin
Sun, Peng
Chen, Hao
author_sort Zhang, Ao
collection PubMed
description
format Online
Article
Text
id pubmed-8641160
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86411602021-12-03 Correction to: Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma Zhang, Ao Zhong, Guanqing Wang, Luocan Cai, Rongzeng Han, Runkun Xu, Caixia Chen, Shulin Sun, Peng Chen, Hao Cancer Cell Int Correction BioMed Central 2021-12-02 /pmc/articles/PMC8641160/ /pubmed/34856989 http://dx.doi.org/10.1186/s12935-021-02369-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Zhang, Ao
Zhong, Guanqing
Wang, Luocan
Cai, Rongzeng
Han, Runkun
Xu, Caixia
Chen, Shulin
Sun, Peng
Chen, Hao
Correction to: Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma
title Correction to: Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma
title_full Correction to: Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma
title_fullStr Correction to: Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma
title_full_unstemmed Correction to: Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma
title_short Correction to: Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma
title_sort correction to: dynamic serum biomarkers to predict the efficacy of pd-1 in patients with nasopharyngeal carcinoma
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641160/
https://www.ncbi.nlm.nih.gov/pubmed/34856989
http://dx.doi.org/10.1186/s12935-021-02369-x
work_keys_str_mv AT zhangao correctiontodynamicserumbiomarkerstopredicttheefficacyofpd1inpatientswithnasopharyngealcarcinoma
AT zhongguanqing correctiontodynamicserumbiomarkerstopredicttheefficacyofpd1inpatientswithnasopharyngealcarcinoma
AT wangluocan correctiontodynamicserumbiomarkerstopredicttheefficacyofpd1inpatientswithnasopharyngealcarcinoma
AT cairongzeng correctiontodynamicserumbiomarkerstopredicttheefficacyofpd1inpatientswithnasopharyngealcarcinoma
AT hanrunkun correctiontodynamicserumbiomarkerstopredicttheefficacyofpd1inpatientswithnasopharyngealcarcinoma
AT xucaixia correctiontodynamicserumbiomarkerstopredicttheefficacyofpd1inpatientswithnasopharyngealcarcinoma
AT chenshulin correctiontodynamicserumbiomarkerstopredicttheefficacyofpd1inpatientswithnasopharyngealcarcinoma
AT sunpeng correctiontodynamicserumbiomarkerstopredicttheefficacyofpd1inpatientswithnasopharyngealcarcinoma
AT chenhao correctiontodynamicserumbiomarkerstopredicttheefficacyofpd1inpatientswithnasopharyngealcarcinoma